Skip to main content

Table 4 Costs per patient month (ppm) by patient subgroup

From: Resource utilisation and cost of ambulatory HIV care in a regional HIV centre in Ireland: a micro-costing study

 

N

Mean drug cost ppm (95% CI)

Mean non-drug costs ppm (95% CI)

Mean total cost ppm (95% CI)

Patient type

    

Existing patient

300

€863 (€829-€897)

€112 (€107-€116)

€975 (€940-€1,010)

New patients

26

€678 (€503-€853)

€253 (€206-€300)

€931 (€732-€1,130)

Gender

    

Male

192

€844 (€805-€882)

€117 (€109-€124)

€960 (€921-€999)

Female

134

€873 (€812-€934)

€118 (€108-€129)

€991 (€927-€1,055)

Age group

    

<50 years

284

€859 (€821-€897)

€121 (€114-€128)

€980 (€941-€1,019)

50+ years

42

€833 (€773-€894)

€94 (€85-€104)

€928 (€871-€984)

Risk factor

    

COHP

133

€878 (€826-€931)

€117 (€106-€127)

€995 (€940-€1,050)

MSM/Bisexual

95

€826 (€769-€884)

€122 (€110-€134)

€948 (€889-€1,007)

Heterosexual

63

€835 (€745-€925)

€113 (€101-€125)

€948 (€856-€1,041)

IDU

18

€931 (€834-€1,027)

€124 (€103-€144)

€1,054 (€942-€1,166)

Other

8

€982 (€733-€1,231)

€92 (€59-€125)

€1,075 (€817-€1,332)

Unknown

9

€697 (€383-€1,012)

€125 (€92-€159)

€823 (€514-€1,132)

Late diagnosis

    

No

135

€810 (€748-€871)

€120 (€111-€130)

€930 (€867-€993)

Unknown

77

€868 (€797-€939)

€115 (€103-€126)

€983 (€908-€1,058)

Yes

114

€902 (€862-€942)

€116 (€104-€127)

€1,018 (€974-€1,062)

Years since diagnosis

    

11+ years ago

95

€879 (€830-€929)

€102 (€95-€108)

€981 (€930-€1,032)

6-10 years ago

107

€890 (€833-€947)

€107 (€99-€115)

€997 (€938-€1,056)

1-5 years ago

100

€831 (€762-€899)

€130 (€119-€141)

€961 (€889-€1,033)

diagnosed in 2012

17

€581 (€349-€812)

€275 (€208-€342)

€855 (€582-€1,128)

Lowest CD4 count in 2012 (cells/μl)

    

500+

168

€888 (€844-€932)

€104 (€98-€110)

€993 (€947-€1,038)

350-499

85

€807 (€734-€879)

€120 (€108-€132)

€927 (€852-€1,002)

200-349

52

€830 (€735-€925)

€129 (€114-€145)

€960 (€861-€1,058)

50-199

14

€839 (€725-€953)

€179 (€115-€244)

€1,018 (€873-€1,164)

<50

7

€903 (€706-€1,100)

€218 (€118-€319)

€1,121 (€842-€1,401)

Treatment and viral load status

    

On HAART, suppressed

211

€939 (€915-€964)

€104 (€100-€109)

€1,043 (€1,017-€1,069)

On HAART, not suppressed

37

€1035 (€987-€1,083)

€154 (€134-€175)

€1,189 (€1,133-€1,245)

On HAART, undetermined status

7

€914 (€776-€1,052)

€84 (€55-€113)

€998 (€845-€1,151)

Started/Stopped HAART

49

€660 (€578-€742)

€169 (€141-€197)

€829 (€733-€924)

Not on HAART

22

-

€103 (€79-€128)

€103 (€79-€128)

Overall

326

856 (822-889)

117 (111-124)

973 (938-1,008)

  1. COHP, person from a country of high prevalence with no other identifiable risk factor available. IDU, current/former injecting drug user. Late diagnosis defined as CD4 count < 350 cells/μl at diagnosis or AIDS defining illness at diagnosis. “On HAART” means the patient was on HAART for the entire duration of the study, “suppressed” was defined as all viral loads in 2012 < 50 copies/ml, with one test result of 50–499 copies/ml allowed if previous and subsequent viral load results were < 50 copies/ml.